MENU
+Compare
OMER
Stock ticker: NASDAQ
AS OF
Dec 26 closing price
Price
$15.71
Change
+$0.35 (+2.28%)
Capitalization
1.09B

OMER Omeros Corp Forecast, Technical & Fundamental Analysis

Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders... Show more

Industry: #Biotechnology
OMER
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for OMER with price predictions
Dec 24, 2025

Aroon Indicator for OMER shows an upward move is likely

OMER's Aroon Indicator triggered a bullish signal on December 19, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 206 similar instances where the Aroon Indicator showed a similar pattern. In of the 206 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 61 cases where OMER's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on December 24, 2025. You may want to consider a long position or call options on OMER as a result. In of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for OMER just turned positive on December 24, 2025. Looking at past instances where OMER's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where OMER advanced for three days, in of 249 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OMER declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

OMER broke above its upper Bollinger Band on December 24, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (26.541). P/E Ratio (0.000) is within average values for comparable stocks, (51.479). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.873). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (311.015).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. OMER’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OMER’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
OMER
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

OMER is expected to report earnings to rise 53.18% to -52 cents per share on March 03

Omeros Corp OMER Stock Earnings Reports
Q4'25
Est.
$-0.52
Q3'25
Beat
by $0.11
Q2'25
Beat
by $0.03
Q4'24
Beat
by $0.15
Q3'24
Beat
by $0.13
The last earnings report on November 13 showed earnings per share of -34 cents, beating the estimate of -44 cents. With 3.92M shares outstanding, the current market capitalization sits at 1.09B.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
201 Elliott Avenue West
Phone
+1 206 676-5000
Employees
198
Web
https://www.omeros.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FAFCX35.350.16
+0.45%
Fidelity Advisor Financials C
PVFYX25.270.10
+0.40%
Victory Pioneer Core Equity Y
FDVLX13.960.04
+0.29%
Fidelity Value
RYGRX90.060.21
+0.23%
Rydex S&P 500 Pure Growth C
NEMRX25.880.01
+0.04%
Neuberger Emerg Mkts Eq R3

OMER and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, OMER has been loosely correlated with GNPX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if OMER jumps, then GNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OMER
1D Price
Change %
OMER100%
+75.54%
GNPX - OMER
51%
Loosely correlated
-1.59%
VCYT - OMER
40%
Loosely correlated
-0.35%
INM - OMER
36%
Loosely correlated
-2.38%
ABSI - OMER
35%
Loosely correlated
+1.14%
XNCR - OMER
32%
Poorly correlated
-0.13%
More